Jeffrey Hung's Stock Ratings

Morgan Stanley Analyst

Jeffrey Hung is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

1.35%

Smart Score

55.4%

Overall Average Return Percentile

39th

Number of Ratings

118
Buy NowGet Alert
05/10/2024FOLDBuy Now
Amicus Therapeutics
$9.46100.85%$20 → $19MaintainsOverweightGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$15.0166.56% → $25Initiates → OverweightGet Alert
04/29/2024PTCTBuy Now
PTC Therapeutics
$34.03-11.84%$28 → $30UpgradeUnderweight → Equal-WeightGet Alert
04/02/2024IRONBuy Now
Disc Medicine
$31.9225.31%$75 → $40MaintainsEqual-WeightGet Alert
03/13/2024ACADBuy Now
ACADIA Pharmaceuticals
$14.89101.48%$40 → $30MaintainsOverweightGet Alert
03/08/2024ENGNBuy Now
enGene Holdings
$14.50175.86% → $40Initiates → OverweightGet Alert
02/20/2024CGONBuy Now
CG Oncology
$30.9777.59% → $55Initiates → OverweightGet Alert
01/16/2024CRNXBuy Now
Crinetics Pharmaceuticals
$51.91-3.68% → $50Initiates → OverweightGet Alert
01/05/2024CYTKBuy Now
Cytokinetics
$59.9250.2%$60 → $90DowngradeOverweight → Equal-WeightGet Alert
12/22/2023KRTXBuy Now
Karuna Therapeutics
$295 → $330DowngradeOverweight → Equal-WeightGet Alert
12/19/2023PTCTBuy Now
PTC Therapeutics
$34.03-17.72% → $28DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023PRLDBuy Now
Prelude Therapeutics
$4.20-4.76%$10 → $4DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023VIGLBuy Now
Vigil Neuroscience
$3.5213.64%$13 → $4DowngradeEqual-Weight → UnderweightGet Alert
12/19/2023IRONBuy Now
Disc Medicine
$31.92103.63%$56 → $65DowngradeOverweight → Equal-WeightGet Alert
12/19/2023RYTMBuy Now
Rhythm Pharmaceuticals
$39.1740.41%$29 → $55UpgradeEqual-Weight → OverweightGet Alert
12/19/2023IVVDBuy Now
Invivyd
$2.4066.67%$1 → $4UpgradeUnderweight → Equal-WeightGet Alert
12/19/2023FOLDBuy Now
Amicus Therapeutics
$9.46111.42%$15 → $20UpgradeEqual-Weight → OverweightGet Alert
12/19/2023ACADBuy Now
ACADIA Pharmaceuticals
$14.89168.64%$31 → $40UpgradeEqual-Weight → OverweightGet Alert
12/08/2023BLUEBuy Now
bluebird bio
$1.08548.15%$3 → $7UpgradeUnderweight → Equal-WeightGet Alert
11/03/2023RAREBuy Now
Ultragenyx Pharmaceutical
$44.2589.81%$90 → $84MaintainsOverweightGet Alert
11/03/2023BCYCBuy Now
Bicycle Therapeutics
$22.1880.34%$42 → $40MaintainsEqual-WeightGet Alert
11/03/2023ACADBuy Now
ACADIA Pharmaceuticals
$14.89108.19%$30 → $31MaintainsEqual-WeightGet Alert
10/27/2023PTCTBuy Now
PTC Therapeutics
$34.03-17.72%$31 → $28MaintainsEqual-WeightGet Alert
10/10/2023RAREBuy Now
Ultragenyx Pharmaceutical
$44.25103.37%$95 → $90MaintainsOverweightGet Alert
10/10/2023RYTMBuy Now
Rhythm Pharmaceuticals
$39.17-25.96%$28 → $29MaintainsEqual-WeightGet Alert
09/18/2023PTCTBuy Now
PTC Therapeutics
$34.03-8.9%$47 → $31MaintainsEqual-WeightGet Alert
08/04/2023RAREBuy Now
Ultragenyx Pharmaceutical
$44.25114.67%$95 → $95ReiteratesOverweight → OverweightGet Alert
08/04/2023PTCTBuy Now
PTC Therapeutics
$34.0338.11%$47 → $47ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023PRLDBuy Now
Prelude Therapeutics
$4.20138.1%$10 → $10ReiteratesEqual-Weight → Equal-WeightGet Alert
08/04/2023KRTXBuy Now
Karuna Therapeutics
$280 → $280ReiteratesOverweight → OverweightGet Alert